Iconiq is particularly well known for overseeing a wide range of business and entertainment titans’ personal portfolios.ENFN currently has some 635 clients, as well as pre-IPO backers that include entities affiliated with FTV Capital, Hillhouse Capital and Iconiq Capital.“Our solution is designed to eliminate technology and information barriers, empowering investment managers to confidently make and execute better-informed investment decisions in real time.” “Enfusion is a global high-growth software-as-a-service provider focused on transforming the investment management industry,” the company wrote in its filing. ![]() The fintech makes end-to-end software solutions for financial firms, covering everything from filling customers’ orders to generating their statements.ENFN wrote in its S-1 that it intends to use the money to buy out pre-IPO investors’ common units, as well as to repay debt, cover some taxes and keep the balance for general corporate purposes.That will rise to about $253.3M if underwriters fully exercise their overallotment options. ENFN added that it expects to net $230.5M if the IPO prices at a midpoint $16/share.All in, the initial public offering will reportedly value ENFN at about $1.9B.ENFN wrote in its S-1 that that arrangement will give insiders and pre-IPO backers some 83.4% of the company’s voting power. Both types of shares will carry one vote apiece, but Class A and B stockholders will vote as a class on company matters.Enfusion ( ENFN) also has Class B stock for insiders and early investors. The company added in its S-1 that Dragoneer Investment Group and pre-IPO backer Iconiq Capital have expressed a nonbinding interest in acquiring up to 20% of the Class A shares.Some 1.5M will come from the company, with pre-IPO investors providing up to 1.3M more. ENFN and its pre-IPO backers have also granted underwriters the option to buy as many as about 2.8M additional Class A shares for overallotments.Pre-IPO investors intend to sell the rest − approximately 3.4M shares. The firm, which plans to list on the New York Stock Exchange under the ticker symbol “ENFN,” will provide about 15.3M Class A shares of the total.Securities and Exchange Commission that the company and certain pre-IPO investors plan to offer the public roughly 18.8M Class A shares within a $15-$17/share range. Enfusion ( ENFN) wrote in a revised S-1 filed with the U.S. ![]() ( ENFN) released specifics Tuesday for an IPO that’s expected to value the fintech at some $1.9B.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |